Rotigaptide protects the myocardium and arterial vasculature from ischaemia reperfusion injury

Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery

(2015) Derek J. Hausenloy et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery

(2015) Patrick Meybohm et al.   NEW ENGLAND JOURNAL OF MEDICINE

The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs

(2013) Andreas Skyschally et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Novel molecular targets for atrial fibrillation therapy

(2012) Dobromir Dobrev et al.   NATURE REVIEWS DRUG DISCOVERY

Roles of Connexins in Atherosclerosis and Ischemia-Reperfusion Injury

(2011) Sandrine Morel et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Ischaemia–reperfusion injury impairs tissue plasminogen activator release in man

(2011) Christian M. Pedersen et al.   EUROPEAN HEART JOURNAL

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

(2010) Hans Erik Bøtker et al.   LANCET

The vascular effects of rotigaptide in vivo in man

(2008) Ninian N. Lang et al.   BIOCHEMICAL PHARMACOLOGY